Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design
在肺炎克雷伯菌OXA-48或铜绿假单胞菌感染的危重患者中,持续输注与间歇给药头孢他啶/阿维巴坦的疗效比较:一项单中心随机开放标签试验(ZAVICONT)。研究原理和设计
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1618987
Momčilović, Mirna; Šitum, Ivan; Erceg, Ante; Siroglavić, Marko; Lovrić, Mila; Nižić Nodilo, Laura; Hafner, Anita; Lovrić, Jasmina; Turčić, Petra; Fabijanović, Dora; Marinić, Ana; Nedeljković, Vanja; Pašalić, Marijan; Perčin, Luka; Šipuš, Dubravka; Miličić, Davor; Lovrić, Daniel